Selective Analysis of Dopamine Receptor Antagonist LE300 and its N-Methyl Metabolite in Mouse Sera at the Trace Level by HPLC–Fluorescence Detection
Abstract A highly selective, sensitive, and reliable high-performance liquid chromatography (HPLC) method was developed and validated for the simultaneous determination of a novel type of dopamine receptor antagonist LE300 and its N-methyl metabolite in mouse sera. LE300, its N-methyl metabolite, and verapamil (an internal standard) were detected using excitation and emission wavelengths of 275 and 340 nm, respectively. HPLC analysis using a deproteinization procedure was performed by injecting an aliquot of the supernatant into the chromatographic system. Chromatographic separation was achieved on a reversed-phase Spherisorb Cyano (CN) column with a mobile phase consisting of acetonitrile:50 mM phosphate buffer pH 3.5 (70:30, v/v) pumped at a flow rate of 1.0 mL $ min^{−1} $. Regression analyses showed excellent linearity (r = 0.999) for concentrations of LE300 ranging from 4 to 500 ng $ mL^{−1} $ and for concentrations of its N-methyl metabolite of 6–600 ng $ mL^{−1} $. The HPLC-FLD method had limits of detection of 1.6 ng $ mL^{−1} $ for LE300 and 2.4 ng $ mL^{−1} $ for its N-methyl metabolite in mouse sera. The precision results, expressed as the intraday and interday relative standard deviation (RSD) values, ranged from 0.65 to 2.85 % (repeatability) and from 0.37 to 2.62 % (intermediate precision) for LE300 and its N-methyl metabolite, respectively; these values are in line with ICH guidelines. The assay was successfully applied in a pharmacokinetic study. The mean values of Tmax and Cmax were 2 h and 25.03 ± 5.60 ng $ mL^{−1} $ for LE300 and 3 h and 19.92 ± 2.88 ng $ mL^{−1} $ for its N-methyl metabolite, respectively..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
---|---|
Enthalten in: |
Chromatographia - 78(2015), 9-10 vom: 21. März, Seite 655-661 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hefnawy, Mohamed [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Fluorescence detection |
---|
RVK: |
---|
Anmerkungen: |
© Springer-Verlag Berlin Heidelberg 2015 |
---|
doi: |
10.1007/s10337-015-2879-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2044361647 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2044361647 | ||
003 | DE-627 | ||
005 | 20230515190255.0 | ||
007 | tu | ||
008 | 200820s2015 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s10337-015-2879-x |2 doi | |
035 | |a (DE-627)OLC2044361647 | ||
035 | |a (DE-He213)s10337-015-2879-x-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 540 |q VZ |
082 | 0 | 4 | |a 540 |q VZ |
084 | |a VA 3820 |q VZ |2 rvk | ||
100 | 1 | |a Hefnawy, Mohamed |e verfasserin |4 aut | |
245 | 1 | 0 | |a Selective Analysis of Dopamine Receptor Antagonist LE300 and its N-Methyl Metabolite in Mouse Sera at the Trace Level by HPLC–Fluorescence Detection |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © Springer-Verlag Berlin Heidelberg 2015 | ||
520 | |a Abstract A highly selective, sensitive, and reliable high-performance liquid chromatography (HPLC) method was developed and validated for the simultaneous determination of a novel type of dopamine receptor antagonist LE300 and its N-methyl metabolite in mouse sera. LE300, its N-methyl metabolite, and verapamil (an internal standard) were detected using excitation and emission wavelengths of 275 and 340 nm, respectively. HPLC analysis using a deproteinization procedure was performed by injecting an aliquot of the supernatant into the chromatographic system. Chromatographic separation was achieved on a reversed-phase Spherisorb Cyano (CN) column with a mobile phase consisting of acetonitrile:50 mM phosphate buffer pH 3.5 (70:30, v/v) pumped at a flow rate of 1.0 mL $ min^{−1} $. Regression analyses showed excellent linearity (r = 0.999) for concentrations of LE300 ranging from 4 to 500 ng $ mL^{−1} $ and for concentrations of its N-methyl metabolite of 6–600 ng $ mL^{−1} $. The HPLC-FLD method had limits of detection of 1.6 ng $ mL^{−1} $ for LE300 and 2.4 ng $ mL^{−1} $ for its N-methyl metabolite in mouse sera. The precision results, expressed as the intraday and interday relative standard deviation (RSD) values, ranged from 0.65 to 2.85 % (repeatability) and from 0.37 to 2.62 % (intermediate precision) for LE300 and its N-methyl metabolite, respectively; these values are in line with ICH guidelines. The assay was successfully applied in a pharmacokinetic study. The mean values of Tmax and Cmax were 2 h and 25.03 ± 5.60 ng $ mL^{−1} $ for LE300 and 3 h and 19.92 ± 2.88 ng $ mL^{−1} $ for its N-methyl metabolite, respectively. | ||
650 | 4 | |a HPLC | |
650 | 4 | |a Fluorescence detection | |
650 | 4 | |a LE300 | |
650 | 4 | |a Trace analysis | |
650 | 4 | |a Pharmacokinetics | |
700 | 1 | |a Alanazi, Amer |4 aut | |
700 | 1 | |a Abounassif, Mohammed |4 aut | |
700 | 1 | |a Mohammed, Mostafa |4 aut | |
700 | 1 | |a Al-Swaidan, Ibrahim |4 aut | |
700 | 1 | |a Attia, Sabry |4 aut | |
700 | 1 | |a Mostafa, Gamal |4 aut | |
700 | 1 | |a El-Subbagh, Hussein |4 aut | |
700 | 1 | |a Lehmann, Jochen |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Chromatographia |d Springer Berlin Heidelberg, 1968 |g 78(2015), 9-10 vom: 21. März, Seite 655-661 |w (DE-627)129269077 |w (DE-600)80097-1 |w (DE-576)014459515 |x 0009-5893 |7 nnns |
773 | 1 | 8 | |g volume:78 |g year:2015 |g number:9-10 |g day:21 |g month:03 |g pages:655-661 |
856 | 4 | 1 | |u https://doi.org/10.1007/s10337-015-2879-x |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-CHE | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_267 | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_4277 | ||
936 | r | v | |a VA 3820 |
951 | |a AR | ||
952 | |d 78 |j 2015 |e 9-10 |b 21 |c 03 |h 655-661 |